Truscreen Group Ltd (TRU) - Total Assets
Based on the latest financial reports, Truscreen Group Ltd (TRU) holds total assets worth AU$4.30 Million AUD (≈ $3.04 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check how aggressively does Truscreen Group Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Truscreen Group Ltd - Total Assets Trend (2013–2024)
This chart illustrates how Truscreen Group Ltd's total assets have evolved over time, based on quarterly financial data. Check Truscreen Group Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Truscreen Group Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Truscreen Group Ltd's total assets of AU$4.30 Million consist of 83.4% current assets and 16.6% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 19.8% |
| Accounts Receivable | AU$433.81K | 23.5% |
| Inventory | AU$538.68K | 29.1% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Truscreen Group Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see TRU company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Truscreen Group Ltd's current assets represent 83.4% of total assets in 2024, an increase from 33.5% in 2013.
- Cash Position: Cash and equivalents constituted 19.8% of total assets in 2024, down from 24.7% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 66.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 29.1% of total assets.
Truscreen Group Ltd Competitors by Total Assets
Key competitors of Truscreen Group Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Inspire Medical Systems Inc
NYSE:INSP
|
USA | $911.38 Million |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
|
China | CN¥1.59 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Stratec SE
XETRA:SBS
|
Germany | €443.38 Million |
|
Scandinavian Medical Solutions AS
CO:SMSMED
|
Denmark | Dkr205.86 Million |
|
Duearity AB
ST:DEAR
|
Sweden | Skr10.84 Million |
Truscreen Group Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.05 | 2.68 | 6.74 |
| Quick Ratio | 4.28 | 1.88 | 6.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$3.25 Million | AU$1.98 Million | AU$5.59 Million |
Truscreen Group Ltd - Advanced Valuation Insights
This section examines the relationship between Truscreen Group Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 13.06 |
| Latest Market Cap to Assets Ratio | 4.58 |
| Asset Growth Rate (YoY) | -54.1% |
| Total Assets | AU$1.85 Million |
| Market Capitalization | $8.46 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Truscreen Group Ltd's assets at a significant premium (4.58x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Truscreen Group Ltd's assets decreased by 54.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Truscreen Group Ltd (2013–2024)
The table below shows the annual total assets of Truscreen Group Ltd from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | AU$1.85 Million ≈ $1.31 Million |
-54.14% |
| 2023-12-31 | AU$4.03 Million ≈ $2.85 Million |
+16.14% |
| 2022-12-31 | AU$3.47 Million ≈ $2.46 Million |
-20.90% |
| 2021-12-31 | AU$4.39 Million ≈ $3.10 Million |
-63.46% |
| 2020-12-31 | AU$12.00 Million ≈ $8.49 Million |
+48.68% |
| 2019-12-31 | AU$8.07 Million ≈ $5.71 Million |
-35.64% |
| 2018-12-31 | AU$12.55 Million ≈ $8.88 Million |
+3.11% |
| 2017-12-31 | AU$12.17 Million ≈ $8.61 Million |
-19.11% |
| 2016-12-31 | AU$15.04 Million ≈ $10.64 Million |
+3.19% |
| 2015-12-31 | AU$14.58 Million ≈ $10.31 Million |
+36.93% |
| 2014-12-31 | AU$10.64 Million ≈ $7.53 Million |
-7.44% |
| 2013-12-31 | AU$11.50 Million ≈ $8.14 Million |
-- |
About Truscreen Group Ltd
TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The comp… Read more